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The regulation of angiogenesis during human skin 
development is poorly understood. Since fibronectin is 
involved in cell movement and organization during em-
bryogenesis and morphogenesis in a variety of species, 
we investigated the expression of fibronectin and factor 
VIII- related antigen, a marker for endothelial cells, at 
various stages in the development of the human cuta-
neous microvasculature. Skin specimens were obtained 
from 4 human fetuses during the second trimester (14-
18 weeks), from newborn foreskins, and from consent-
ing normal adults. Cryostat sections were stained with 
both fluorescein-conjugated rabbit antihuman fibronec-
tin and rhodamine-conjugated goat antihuman factor 
.VIII-related antigen. Expression of fibronectin in the 
microvasculature was striking in fetal skin but became 
progressively less prominent with maturation. Fibro-
nectin appeared in fetal blood vessels as a bright contin-
uous linear array, in neonatal blood vessels as a bright 
interrupted linear and speckled array, and in adult 
blood vessels as a sparse interrupted linear and speckled 
array. In contrast, expression of factor VIII-related an-
tigen by the endothelium became more prominent w ith 
the degree of maturation of the microvasculature. Gran-
ular factor VIII-related antigen staining was scant in 
the newly forming blood vessels of fetal skin, bright but 
focal in the microvasculature of newborn skin, and in-
tense and almost confluent in the blood vessels of adult 
skin. Although expression of fibronectin and factor 
VIII- related antigen changed, expression of laminin was 
consistent throughout development. Staining of the 
same skin specimens with fluorescein-conjugated sheep 
antihuman laminin produced a bright continuous linear 
pattern in all blood vessels. The reciprocal relationship 
manifested by intense fibronectin staining during hu-
man blood vessel development and prominent factor 
VIII-related antigen staining in mature blood vessels 
supports the hypotheses that fibronectin plays a role in 
human blood vessel modulation and morphogenesis, and 
that factor VIII-related antigen is a marker for endo-
thelial cell differentiation. 
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Fibronectin, a 440 kD glycoprotein, promotes cell-cell and 
cell-matrix interactions in vitro [1,2], and has been shown to 
be increased in vivo in tissues undergoing modification during 
embryogenesis and morphogenesis [3-6], inflammation [7,8], 
tumor growth [9,10], and wound repair [11-13]. This accentua-
tion of fibronectin in areas of intense cellular activity during 
tissue growth and reorganization suggests that fibronectin may 
provide a provisional substratum which promotes cell adhesion, 
migration, and proliferation [2] . The concept that increased 
tissue fibronectin may have functional significance is substan-
tiated by the fact that antibodies to fibronectin prevent the 
invagination in vivo of presumptive mesodermal cells during 
gastrulation in amphibian embryos [6] and inhibit the migra-
tion in vitro of avian trunk neural crest cells [14] . 
The mechanisms responsible for angiogenesis and blood ves-
sel remodeling during human skin development have not been 
identified. Since fibronectin accumulation has been demonstra-
ted in activated proliferating and remodeling blood vessels 
during inflammation in human [8] and guinea pig skin [7] and 
during cutaneous wound repair in the guinea pig [12] and rat 
[13], we investigated whether the expression of fibronectin in 
the human cutaneous microvasculature might be increased 
during development, a time of blood vessel formation, prolif-
eration, and remodeling [15- 16] . Using a double-label immu-
nofluorescence technique in which sections of fetal, neonatal, 
and adult human skin were stained for both fibronect in and 
factor VIII-related antigen, a marker for endothelial cells, we 
have determined that fibronectin expression is prominent in 
developing blood vessels and decreases with maturation of the 
microvasculature. 
MATERIALS AND METHODS 
Skin Specimens 
Skin samples were obtained from the abdomen of 4 presumed normal, 
aborted human fetuses, ranging from 14- 18 weeks' gestation, and from 
4 human neonatal foreskins, and were compared with 4-mm punch 
skin biopsies from 3 normal consenting adults, one of which was from 
the abdomen. Fetal skin was acquired after written consent from 
mothers undergoing elective saline- induced abortions. All skin speci-
mens were snap-frozen in liquid nitrogen and stored at -7o·c until 
ready for sectioning. 
Immunofluorescence Reagents 
Antihuman factor VIII-related antigen: Goat antibodies to human 
factor VIII-related antigen (lgG fraction) were purchased from Atlantic 
Antibodies (Scarborough, Maine) and conjugated with rhodamine by 
the dialysis method [17). Specificity for factor VIII-related antigen 
could be demonstrated by staining of cultured human umbilical vein 
endothelial cells, but not foreskin fibroblasts, in a characteristic gran-
ular pattern . In addition, all fluorescence activity had been previously 
shown to be depleted by absorption with factor VIII preparations but 
not with von Willebrand factor-deficient plasma [12). 
Antihuman fibronectin: Antisera were raised in rabbits [18) to fibro-
nectin purified from human plasma [19). Antihuman fibronectin anti-
bodies were purified by DEAE chromatography, ammonium sulfate 
precipitation, and affinity absorption both with insolubilized fibronec-
tin-free serum and with fibrinogen bound to 48 Sepharose as previously 
described [7); and conjugated with fluorescein by the dialysis method 
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[ 1 7]. Specificity for fibronectin could be demonstrated by staining of 
cultured human fibroblasts , but not a fibrin clot, in a typical fibrillar 
pattern. Fibroblast staining could be removed by prior absorption of 
antibodies with purified fibronectin [20]. 
Antihuman larnin.in: Sheep a ntibodies were raised to mouse laminin 
that was purchased from Bethesda Research Laboratories (Fredricks-
berg, Ma ryland) and conjugated with fluorescein by t he dialysis method 
[1 7). Specificity for la minin , but not type IV collagen, fibronectin, or 
types I and III collagen was demonstrated by an enzyme-linked irn-
munosorbant assay (ELISA). 
I rnmunofluorescence Procedure 
Each skin specimen was double-labeled with both fluorescein-con-
jugated antihuman fibronectin or antihuman laminin and rhodamine-
conjugated antihuman factor VIII-related ant igen by the following 
procedure: 
Skin samples t hat had been snap -frozen in liquid ni t rogen were 
e mbedded in Tissue-Tek II O.C.T. Compound (Lab-Tek P roducts, 
Naperville, Illinois). Four-micron cryostat sections were heat-fixed to 
microscope slides, washed once in phosphate-buffered saline pH 7.4 
(PBS) and then incubated with both conjugated antibodies (1:500 
dilution in PBS with 0.1 % sodium azide) for a minimum of 2 hat room 
temperature. Slides were then rinsed in PBS for 10 min, dipped in 
cold water, dipped in 50% acetone, soaked in 100% acetone for 1 min , 
air-dried, a nd fina lly mounted in a glycerol-PBS mounting buffer 
containing 0.1 % para -phenylenediamine (PPD) [21] which causes faint 
background cellula r fluorescence but diminishes quenching of specific 
fluorescein staining. Double-labeled sections were viewed and photo-
graphed wi th a Zeiss immunoflu orescence microscope with epi-illumi-
n ation through a 40X objective and filter systems for both fluorescein 
and rhodamine. To permit direct comparison of photomicrographs, 
exp osure t imes and magnification were kept constant. Adjacent sec-
tions stained with Giemsa were used to confi rm morphologically the 
size and distribution of blood vessels. 
RESULTS 
Double-labeling of t he same skin sections with bot h fluores -
cein-conjugated antifibronectin and rhodamine-conjugated 
anti-factor VIII-related antigen enabled direct comparison of 
the degree and intensity of staining for the two an t igens at 
each stage of skin development, as illustrated in Figs 1-3. In 
fetal skin, the newly forming blood vessels stained for fibronec -
tin in a bright continuous linear pattern (Fig 1A ), while factor 
VIII-related antigen staining of the same immature fetal vessels 
was granular, scant, and focal (Fig 1B). Fibronectin staining of 
blood vessels in the papillary dermis of neonatal skin was less 
prominent compared to staining of fetal vessels, occurring in a 
bright but broken linear and speckled pattern (Fig 2A ). Factor 
VIII-related antigen staining of the same neonatal vessels 
occurred in a bright focal pattern (Fig 2B), more prominent 
than in fetal vessels. Adult blood vessels stained minimally for 
fibronectin in a sparse, broken linear and speckled pattern (Fig 
3A ). Factor VIII-related antigen staining was bright and almost 
confluent in t he superficial microvasculature of adult skin (Fig 
3B). 
Double- labeling of skin sections with both fluorescein-con-
jugated ant ilaminin and rhodamine-conjugated ant i-factor 
VIII-related ant igen is illustrated in Figs 4- 6. Laminin expres-
sion in the cutaneous microvasculature demonstrated a bright 
continuous linear pattern in all sections examined at each stage 
of development (Figs 4A , SA, 6A). In contrast, factor VIII-
related ant igen expression became more prominent with cuta-
neous maturation (Figs 4B, 5B, 6B) as noted previously (Figs 
lB, 2B, 3B). 
In summary, laminin expression in blood vessels was con-
sistent ly bright and linear in fetal, neonatal, and adult skin . 
The expression of fibronectin in blood vessels was bright and 
linear in fetal skin, bright and speckled in neonatal skin, and 
sparse and speckled in adult skin . In contrast, factor VIII-
related antigen expression in blood vessels was scant in fetal 
skin, focal in neonatal skin , and confluent in adult skin. The 
rec iprocal relationship in the expression of fibronectin and 
factor VIII-related antigen was confirmed with double-exposure 
color photographs (not shown) in which fetal vessels stained 
predominately for fibronectin (green-fluorescein), adult ves-
sels stained predominately for factor VIII-related antigen 
(red- rhodamine), and neonatal vessels stained about equally 
for both fibronectin and factor VIII-related antigen (green-
fluorescein and red-rhodamine) . 
DISCUSSION 
In this study, human fetal , neonatal, and adult skin were 
examined by a double-label immunofluorescence technique to 
investigate the expression of fibronectin, a glycoprotein which 
mediates cell migration and proliferation, factor VIII-related 
antigen, a marker for endothelial cells, and laminin, a basement 
membrane glycoprotein, in the developing cutaneous microva~­
culature. The data presented here demonstrate that fib~onect~n 
expression in human cutaneous blood vessels was promment m 
fetal skin and progressively decreased with maturation; in 
contrast, expression offactor VIII-related antigen became more 
prominent with t he degree of maturation of the microvascula-
ture. Laminin expression in blood vessels was prominent and 
consistent throughout development. 
In normal skin fibronectin distribution in blood vessel walls 
appears as spars~ interrupted linear and speckled staining by 
immunofluorescence [12,22,23] (Fig 3A ). In vivo studies have 
demonstrated that the expression of fibronectin in small blood 
vessels greatly increases when the microvasculature undergoes 
proliferation and repair in response to injury as a result of 
either inflammation [7,8] or wounding [12,13], in contrast to 
the normal expression of fibronecti n [22] in ectatic but n?n-
proliferative [24] blood vessels, such as those in port-wn:e 
stains. In excisional wound repair in t he guinea pig, fibronectm 
is markedly accentuated in the proliferating blood vessels 
around the perimeter of the wound and also in the neovascu-
lature that grows into the granulation tissue [12]. By the use 
of a rat-mouse xenograft wound model system and reciprocal 
species-specific antifibronect in antibodies, the increased fibro -
nectin in the microvascular wall was shown to be produced in 
situ, in association with proliferating endothelial cells, and not 
to be passively absorbed from plasma [13]. . . 
Our study, as reported here, did not permit determmat10n of 
the source of increased fibronectin in t he developing and pro-
liferating microvasculature of human skin. However, in vitro 
studies lend credence to t he concept that fibronectin is pro-
duced in situ by activated proliferating endothelial cells since, 
in tissue culture human umbilical vein endothelial cells [25] as 
well as bovine ;orta endothelial cells [26] not only synthesize 
and secrete fibronectin but also deposit significant quantities 
in the pericellular matrix [27]. A potential in vivo funct ion for 
increased fibronectin deposition is suggested by the fact that 
in tissue culture fibronectin can bind to biologic substratum, 
such as collagen ~r fibrinogen (fibrin), and simultaneously bind 
to cell surfaces such as fibroblasts, and thereby promote at-
tachment, spre~ding, and growth of t hese cells [1] . I_n addition, 
fibronectin and/ or its fragments can induce migratiOn of cells 
such as fib roblasts [28] and monocytes [29]. These _in vitro 
observations have recently been extended to endothelial ~ells. 
Fibronectin specifically promotes adherence of human ad1pose 
microvascular endot helial cells in vitro to collagen substrates 
compared with other extracellular mat rix proteins [30] . In the 
fluid phase, fibronectin and/or fibronectin fragme~ts are chem-
otactic for isolated endothelial cells (31]. Our findmgs reported 
here, in context with t he studies cited above, suggest t hat t he 
increased fibronectin in developing and regenerating blood 
vessels may facilitate endothelial cell migration and prolifera-
tion during neovascularization. 
Factor VIII-related antigen , a component of the factor VIII 
complex which circulates in human plasma, is synthesized and 
secreted by cultured human umbilical vein and microvascular 
endot helial cells in vitro [32-34] and is considered to be a 
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FIG 1. Double- label immunofluorescence study of human fetal skin section stained with both fluorescein-conjugated a nt ihuman fibronectin 
(A) and rhodamine-conjugated a nt ihuman facto r VIII-related a nt igen (B) . Bar = 50 ,.,m. Antifibronectin stained newly forming blood vessels in 
a bright linear patte rn (A) in cont rast to scant staining with anti-factor VIII-related ant igen (B) . 
FIG 2. Double- label immunofluorescence study of huma n neonatal skin section stained wi th both fluorescein -conjugated ant ihuman fibronectin 
(A ) a nd rhodamine-conjugated a nt ihuman facto r VIII-related a nt igen (B ). B ar = 50 ,.,m. Blood vessels in the papillary dermis stained for 
fi bronectin (A) in a bright speckled pattern and for facto r VIII-related ant igen (B) in a comparable bright focal pattern . 
F IG 3. Double- label immunofluorescence study of human adult skin section stained wi th both fluorescein-conjugated ant ihuma n fibronectin 
(A) and rhodam ine-conjugated ant ihuman facto r VIII- related ant igen (B ). Bar = 50 J.Lm. Blood vessels in the papillary dermis stained fo r 
fi bronectin (A) in a fa in t speck led patte rn in cont rast to the bright almost confluent facto r VIII-related ant igen staining (B). 
t issue-specific marker for vascular endothelium in vivo [35-
37]. In this study we have dete rmined t hat expression of factor 
VIII-related ant igen is less prominent in the immature prolif-
erating and organizing blood vessels of fetal (Fig l B) and 
neonata l (Fig 2B ) skin , suggesting a specificity of factor VIII -
related ant igen for mature blood vessels (Fig 3B) . 
Laminin is a noncollagenous glycoprotein present in base-
ment membranes of human and animal t issue, which has been 
localized to the lamina Iucida [38]. Our finding of prominent 
laminin expression in blood vessels at each stage of develop-
ment is in agreement with previous reports [39,40] which 
demonstrated that laminin is expressed in the microvasculature 
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FIG 4. Double-label immunofluorescence study of human fetal skin section stained with both fluorescein-conjugated antihuman laminin (A) 
and rhodamine-conjugated a nt ihuman factor VIII-related a nt igen (B) . Bar= 50 ,.,m. Antilaminin stained newly forming blood vessels in a bright 
linear patte rn (A) in contrast to scant staining with ant i-factor VIII-related antigen (B). . .. 
FIG 5. Double- label im munofluorescence study of human neonatal skin section stained with both fluorescein-conjugated ant ihuman lammm 
(A) a nd rhodam ine-conjugated antihuman factor VII I-related a nt igen (B). Bar= 50 ,.,111 • Blood vessels in the papillary derm is stai ned for lamini n 
(A) in a bright linear pattern in contrast to t he bright focal pattern of factor VIII-re lated antigen staining (B). . .. 
F1 G 6. Double-label immunofluorescence study of human adult skin section stained with both fluorescein-conjugated antihuman lammm (A) 
and rhodamine-conjugated antihuman factor VIII-related antigen (B) . Bar= 50 ,.,m. Blood vessels in the papillary dermis stained fo r laminin 
(A) in a bright linear pattern comparable to t he bright almost confluent factor VIII-related antigen staining (B). 
of human fetal skin as early as 6-7 weeks gestational age and 
persists unchanged throughout development. 
In contrast to consistently prominent laminin staining at all 
developmental stages, the reciprocal relat ionship manifested 
by intense fibronectin staining during human blood vessel 
development and prominent factor VIII-related antigen stain-
ing in mature blood vessels supports the hypotheses that fibro-
nectin plays a role in human blood vessel modulation and 
morphogenesis and that factor VIII-related antigen is a marker 
for endothelial cell differentiation. 
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